|
US5866375A
(en)
*
|
1991-10-31 |
1999-02-02 |
Chiron S.P.A. |
Method for the culture of microorganisms of the genera helicobacter, campylobacter and arcobacter employing culture media comprising cyclodextrins
|
|
US5721349A
(en)
*
|
1992-02-26 |
1998-02-24 |
Vanderbilt University |
Vacuolating toxin-deficient H. pylori
|
|
CA2117490C
(en)
*
|
1992-02-26 |
2009-01-06 |
Timothy L. Cover |
Purified vacuolating toxin from helicobacter pylori and methods to use same
|
|
US5928865A
(en)
*
|
1992-03-02 |
1999-07-27 |
Chiron S.P.A. |
Compositions comprising isolated Helicobacter pylori CagI polynucleotides and method of preparation thereof
|
|
IT1262896B
(it)
*
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
MX9301706A
(es)
*
|
1992-04-13 |
1994-05-31 |
Oravax Inc |
Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
|
|
US5403924A
(en)
*
|
1992-10-13 |
1995-04-04 |
Vanderbilt University |
Taga gene and methods for detecting predisposition to peptic ulceration
|
|
US5733740A
(en)
*
|
1992-10-13 |
1998-03-31 |
Vanderbilt University |
Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
|
|
US5972336A
(en)
*
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
|
US6290962B1
(en)
*
|
1992-11-03 |
2001-09-18 |
Oravax, Inc. |
Urease-based vaccine and treatment for helicobacter infection
|
|
WO1995014093A1
(en)
|
1993-05-19 |
1995-05-26 |
Institut Pasteur |
Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
|
|
US6258359B1
(en)
|
1993-05-19 |
2001-07-10 |
Institut Pasteur |
Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
|
|
GB9313279D0
(en)
*
|
1993-06-28 |
1993-08-11 |
Medical Res Council |
Protection against infection with helicobacter pylori
|
|
US6406703B1
(en)
|
1993-07-27 |
2002-06-18 |
Csl Limited |
Treatment of H. pylori associated gastroduodenal disease
|
|
KR100333113B1
(ko)
*
|
1993-07-27 |
2002-11-27 |
시에스엘 리미티드 |
헬리코박터피롤리관련위십이지장질환의치료방법
|
|
US5750119A
(en)
*
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
*
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
GB2290710B
(en)
*
|
1994-06-29 |
1998-03-25 |
Reckitt & Colmann Prod Ltd |
Protease from helicobacter pylori for use in vaccines/therapeutic compositions
|
|
JPH10502365A
(ja)
*
|
1994-07-01 |
1998-03-03 |
リカン・リミテッド |
ヘリコバクタータンパク質およびワクチン
|
|
GB9505438D0
(en)
*
|
1995-03-17 |
1995-05-03 |
Sod Conseils Rech Applic |
Antisense oligonucleotides
|
|
AU6343696A
(en)
*
|
1995-07-07 |
1997-02-10 |
Oravax, Inc |
Helicobacter clpb
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5837251A
(en)
*
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
*
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
AU3657995A
(en)
*
|
1995-10-09 |
1997-04-30 |
Pasteur Merieux Serums Et Vaccins |
Helicobacter lactoferrin receptor
|
|
WO1997025429A1
(en)
*
|
1996-01-04 |
1997-07-17 |
Rican Limited |
Helicobacter pylori bacterioferritin
|
|
JPH1033179A
(ja)
*
|
1996-07-24 |
1998-02-10 |
Fuso Yakuhin Kogyo Kk |
感染症診断用プローブ
|
|
AU4311697A
(en)
*
|
1996-09-20 |
1998-04-14 |
Cortecs International Limited |
Adhesins from heliobacter pylori and their diagnostic and therapeutic uses
|
|
AU5697898A
(en)
*
|
1996-12-19 |
1998-07-15 |
Chiron Corporation |
(helicobacter pylori) diagnostics
|
|
US6017540A
(en)
*
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
*
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
BR9809426A
(pt)
*
|
1997-04-30 |
2000-06-13 |
Merieux Oravax |
Composição de vacina anti-helicobacter para uso pela via sistêmica subdiafragmática e método de imunização mucosal/parenteral combinado
|
|
FR2748477B1
(fr)
*
|
1997-07-01 |
2001-07-13 |
Pasteur Merieux Serums Vacc |
Nouvelle proteine membranaire d'helicobacter pylori
|
|
US6914131B1
(en)
|
1998-10-09 |
2005-07-05 |
Chiron S.R.L. |
Neisserial antigens
|
|
WO1999035270A1
(en)
*
|
1997-12-31 |
1999-07-15 |
Stressgen Biotechnologies Corporation |
Streptococcal heat shock proteins of the hsp60 family
|
|
US6585975B1
(en)
*
|
1998-04-30 |
2003-07-01 |
Acambis, Inc. |
Use of Salmonella vectors for vaccination against helicobacter infection
|
|
WO1999057278A2
(en)
*
|
1998-04-30 |
1999-11-11 |
Chiron S.P.A. |
IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
|
|
US6838553B1
(en)
*
|
1999-10-05 |
2005-01-04 |
Academia Sinica |
Peptide repeat immunogens
|
|
GB9924060D0
(en)
*
|
1999-10-11 |
1999-12-15 |
Chiron Spa |
VIP54 protein
|
|
RU2281956C2
(ru)
|
1999-10-29 |
2006-08-20 |
Чирон С.Р.Л. |
Антигенные пептиды neisseria
|
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
US20020107368A1
(en)
*
|
2000-12-07 |
2002-08-08 |
Jing-Hui Tian |
Helicobacter proteins, gene sequences and uses thereof
|
|
AU2002303330B2
(en)
|
2001-05-31 |
2008-07-24 |
Novartis Vaccines And Diagnostics, Inc. |
Chimeric alphavirus replicon particles
|
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
|
HK1079705A1
(zh)
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
EP2572707A3
(en)
|
2002-02-20 |
2013-11-06 |
Novartis Vaccines and Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
|
JP4726485B2
(ja)
*
|
2002-08-02 |
2011-07-20 |
大日本住友製薬株式会社 |
細菌細胞壁骨格成分製剤
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
EP2395073B1
(en)
|
2002-11-01 |
2017-09-06 |
GlaxoSmithKline Biologicals S.A. |
Drying process
|
|
EP1562982B1
(en)
|
2002-11-15 |
2010-05-05 |
Novartis Vaccines and Diagnostics S.r.l. |
Unexpected surface proteins in neisseria meningitidis
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
|
US7731967B2
(en)
|
2003-04-30 |
2010-06-08 |
Novartis Vaccines And Diagnostics, Inc. |
Compositions for inducing immune responses
|
|
EP1631264B8
(en)
|
2003-06-02 |
2017-05-24 |
GlaxoSmithKline Biologicals SA |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
|
WO2005019265A1
(en)
|
2003-08-13 |
2005-03-03 |
Chiron Corporation |
Improved method of purifying tfpi and tfpi analogs
|
|
EP1730171A1
(en)
|
2004-02-19 |
2006-12-13 |
Ramot at Tel Aviv University Ltd. |
Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof
|
|
CA2564180A1
(en)
*
|
2004-04-22 |
2005-11-03 |
Dainippon Sumitomo Pharma Co., Ltd. |
Pharmaceutical preparation containing bacterial cell wall skeleton component
|
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
免疫増強用の化合物
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
ATE447021T1
(de)
|
2004-06-24 |
2009-11-15 |
Yissum Res Dev Co |
Verwendung von peptid-mimotopen von mannosylierten lipoglycanen aus mycobacterien zur behandlung von entzündungen
|
|
EP1784211A4
(en)
|
2004-07-29 |
2010-06-30 |
Novartis Vaccines & Diagnostic |
IMMUNOGENIC COMPOSITIONS FOR GRAMPOSITIVE BACTERIA SUCH AS STREPTOCOCCUS AGALACTIAE
|
|
EP1838340B1
(en)
|
2004-12-22 |
2018-04-04 |
Cleveland Clinic Foundation |
Flagellin related polypeptides and uses thereof
|
|
CA2626253A1
(en)
|
2005-10-18 |
2007-04-26 |
Novartis Vaccines And Diagnostics, Inc. |
Mucosal and systemic immunizations with alphavirus replicon particles
|
|
CA2630220C
(en)
|
2005-11-22 |
2020-10-13 |
Doris Coit |
Norovirus and sapovirus antigens
|
|
CA2646539A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
KR100846494B1
(ko)
*
|
2006-09-26 |
2008-07-17 |
삼성전자주식회사 |
헬리코박터 파일로리의 표적 서열을 증폭하기 위한프라이머 세트, 상기 프라이머 세트를 이용하여 헬리코박터파일로리를 검출하는 방법 및 상기 프라이머 세트를포함하는 헬리코박터 파일로리를 검출하는 키트
|
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
|
PL2235046T3
(pl)
|
2007-12-21 |
2012-12-31 |
Novartis Ag |
Zmutowane formy streptolizyny O
|
|
EP2320948B1
(en)
|
2008-08-01 |
2013-03-06 |
Cleveland Biolabs, Inc. |
Methods for treating reperfusion injuries
|
|
NZ591768A
(en)
|
2008-09-18 |
2012-11-30 |
Novartis Ag |
Vaccine adjuvant combinations
|
|
CN102481349B
(zh)
|
2009-01-12 |
2014-10-15 |
诺华股份有限公司 |
抗革兰氏阳性细菌疫苗中的Cna_B结构域
|
|
CN102740882A
(zh)
|
2009-08-27 |
2012-10-17 |
诺华有限公司 |
含有铝、寡核苷酸和聚阳离子的佐剂
|
|
ES2443952T3
(es)
|
2009-09-02 |
2014-02-21 |
Novartis Ag |
Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
|
|
KR20130121699A
(ko)
|
2010-05-28 |
2013-11-06 |
테트리스 온라인, 인코포레이티드 |
상호작용 혼성 비동기 컴퓨터 게임 기반구조
|
|
ES2458355T3
(es)
|
2010-09-01 |
2014-05-05 |
Novartis Ag |
Adsorción de inmunopotenciadores sobre sales metálicas insolubles
|
|
US9618508B2
(en)
|
2010-12-14 |
2017-04-11 |
Glaxosmithkline Biologicals Sa |
Flow cytometry analysis of materials adsorbed to metal salts
|
|
WO2012097012A1
(en)
|
2011-01-10 |
2012-07-19 |
Cleveland Biolabs, Inc. |
Use of toll-like receptor agonist for treating cancer
|
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
|
MX346678B
(es)
|
2012-03-07 |
2017-03-29 |
Novartis Ag |
Sales de arginina utiles inmunologicamente.
|
|
JP2015510872A
(ja)
|
2012-03-07 |
2015-04-13 |
ノバルティス アーゲー |
Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤
|
|
MX372965B
(es)
|
2012-03-08 |
2020-04-01 |
Glaxosmithkline Biologicals Sa |
Formulaciones adyuvadas de vacunas de difteria, tetanos y tos ferina (dtp) de refuerzo.
|
|
WO2014016301A1
(en)
*
|
2012-07-23 |
2014-01-30 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
A protein microarray for characterizing the specificity of the monoclonal immunoglobulins of mgus or myeloma patients
|
|
US10202426B2
(en)
|
2014-07-30 |
2019-02-12 |
Genome Protection, Inc. |
Flagellin compositions and uses
|
|
US10183056B2
(en)
|
2014-10-16 |
2019-01-22 |
Cleveland Biolabs, Inc. |
Methods and compositions for the treatment of radiation-related disorders
|
|
SE541618C2
(en)
*
|
2017-02-24 |
2019-11-12 |
Biotome Pty Ltd |
Novel peptides and their use in diagnosis
|